Puma Biotechnology | PBYI - Ebit





Ebit Cambiamento Data
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 137.59M 108.19M 2026-03
Amgen USD 3.83B 130M 2026-03
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Exelixis USD 251.34M 15.43M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
Glaxosmithkline GBP 2.3B 1.46B 2025-12
Incyte USD 344.17M 39.71M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
Moderna USD -1.39B 531M 2026-03
Novartis USD 4.18B 118M 2026-03
Pfizer USD 4.99B 340M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
Takeda JPY -13.62B 271.11B 2026-03
TG Therapeutics USD 34.8M 15.7M 2026-03
Ultragenyx Pharmaceutical USD -216M 102M 2026-03
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Vertex Pharmaceuticals USD 1.14B 124.5M 2026-03